Coccidioidomycosis laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Coccidioidomycosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes Coccidioides immitis Coccidioides posadasii
Differentiating Coccidioidomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Coccidioidomycosis laboratory tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Coccidioidomycosis laboratory tests All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Coccidioidomycosis laboratory tests
CDC on Coccidioidomycosis laboratory tests
Coccidioidomycosis laboratory tests in the news
Blogs on Coccidioidomycosis laboratory tests
Directions to Hospitals Treating Coccidioidomycosis
Risk calculators and risk factors for Coccidioidomycosis laboratory tests

Diagnostic test

The fungal infection can be demonstrated by microscopic detection of diagnostic cells in body fluids, exudates, sputum and biopsy-tissue. With specific nucleotide primers C.immitis DNA can be amplified by PCR. It can also be detected in culture by morphological identification or by using molecular probes that hybridize with C.immitis RNA. An indirect demonstration of fungal infection can be achieved also by serologic analysis detecting fungal antigen or host antibody produced against the fungus.